New data reveals the states with the largest increase in obesity rates in the last decade; experts blame poor access to ...

Many patients taking obesity and diabetes drugs like Ozempic and Wegovy have found its benefits go beyond weight loss.

Target action dates for drugs sponsored by Sanofi, Boehringer Ingelheim and Disc Medicine have also been pushed back despite ...

The Obesity Association, a division of the American Diabetes Association (ADA), has issued new standards of care on the ...

SAN FRANCISCO -- Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower mortality and ...

A team led by UT Southwestern Medical Center researchers has uncovered a molecular pathway that links obesity to widespread ...

The health-care corner of the US equity market has traditionally been viewed as defensive, thanks to steady growth and healthy dividend yields among the industry’s stalwarts. That narrative is ...

"Based on our findings, berberine should not be recommended specifically for reducing liver fat or visceral fat in ...

In a landmark move for UK patients with obesity, the Medicines and Healthcare products Regulatory Agency (MHRA) has approved ...

Nearly all of us have seen the ads and commercials for weight loss medications like Ozempic and Mounjaro, but how common are ...

New research calls for routine risk stratification of MASLD in people with obesity to detect and manage liver disease earlier ...

A surge in obesity treatment demand has reduced passenger weight, leading U.S. airlines to save up to $580 million (850 ...